Methodology

All entries for: Agiana Pharmaceuticals

March 30, 2026

Agiana Pharmaceuticals

Orphan Drug Designation

treatment of catecholaminergic polymorphic ventricular tachycardia

Disease Area: Rare Diseases
Source
Scroll to Top